Company: LRHC
Filing Date: 2025-09-25
Form Type: S-1
Source: 0001213900-25-091637
Chunk: 32

Company: La Rosa Holdings Corp.
Filing Date: 2025-09-25
Form: S-1
Chunk 32
---
 to the Facility, we will have discretion,
subject to market demand, to vary the timing, prices, and numbers of shares sold to the Selling Stockholder. If and when we do elect to
sell shares of our common stock to the Selling Stockholder pursuant to the Facility, after the Selling Stockholder has acquired such shares,
the Selling Stockholder may resell all, some or none of such shares at any time or from time to time in its discretion and at different
prices. As a result, investors who purchase shares from the Selling Stockholder in this offering at different times will likely pay different
prices for those shares, and so may experience different levels of dilution and in some cases substantial dilution and different outcomes
in their investment results. Investors may experience a decline in the value of the shares they purchase from the Selling Stockholder
in this offering as a result of future sales made by us to the Selling Stockholder at prices lower than the prices such investors paid
for their shares in this offering. Further, the sale of a substantial number of shares of our common stock by the Selling Stockholder,
or anticipation of such sales, could cause the trading price of our common stock to decline or make it more difficult for us to sell equity
or equity-related securities in the future at a time and at a price that we might otherwise desire.

We may not have access to the full amount available under the Facility with the Selling Stockholder. We may require additional financing to sustain our operations, without which we may not be able to continue operations, and the terms of subsequent financings may adversely impact our stockholders.

We may direct the Selling Stockholder to purchase
up to $1,000,000,000 worth of shares of our common stock in a “regular purchase” (as set forth in the Facility) from time
to time under the Facility over a 36-month period generally in amounts of shares of common stock that vary depending on the closing sale
price of our common stock at the time of sale. Moreover, under certain circumstances as set forth in the Facility, we may, in our sole
discretion, also direct the Selling Stockholder to purchase additional shares of common stock in “accelerated purchases” as
set forth in the Facility.

<div align='center'>16</div>

Depending on the prevailing market price of our
common stock, we may not be able to sell shares to the Selling Stockholder for the maximum $1,000,000,000 over the term of the Facility.
In